化瘀消肿凝胶对面部整形术后肿胀影响的临床和实验研究
|
摘要
目的
探讨减轻面部整形术后肿胀或加快术后肿胀消退的治疗方法。根据马钱子碱外用治疗肿胀安全有效,将其复合磷脂传递体化后增加其透皮吸收率,成功制备出主药为马钱子优化总生物碱复合磷脂传递体的化瘀消肿凝胶。将此凝胶在小鼠耳致炎肿胀模型上进行抗炎消肿的实验研究,并进行隆鼻术后消肿治疗的临床观察,探讨化瘀消肿凝胶对面部整形术后肿胀的治疗效果,为化瘀消肿凝胶的临床应用提供可靠的实验数据和理论依据。
方法
1.理论研究阅读中西医学相关文献,整理分析。
2.实验研究
(1)制备化瘀消肿凝胶：从马钱子总生物碱中去除毒性成分士的宁,提取无毒的、有消肿作用的马钱子优化总生物碱,载入复合磷脂传递体,并制作成凝胶制剂,是为化瘀消肿凝胶。
(2)化瘀消肿凝胶抗炎消肿实验：将小鼠右耳涂抹二甲苯致肿,左耳不涂药作为对照造模。对照组给予含20%乙醇的PBS,给药组给予化瘀消肿凝胶,末次给药后用打孔器在左右两耳相同部位打下圆耳片,称重并记录,计算出耳肿胀度和抑肿率。同理,进行了预防给药后造模、末次给药间隔时间、最佳给药剂量等实验。
3.临床研究
采用随机平行对照的临床试验方法,观察进行假体(膨体或硅胶)隆鼻手术的女性患者病例数120例,共计分为六组：膨体治疗组、硅胶治疗组、膨体对照组、硅胶对照组、膨体空白组、硅胶空白组,每组20例。治疗组的患者从术后即刻予化瘀消肿凝胶外敷(15g/次)至术后第七天,对照组的患者从术后即刻予冰敷(12h/天)至术后第七天,空白组的患者手术区域不予任何处理。所有患者均于术前、术后1天、3天、5天、7天五个时间点分别进行面部三维扫描,通过软件分析得到不同时间点的肿胀厚度、肿胀体积及肿胀度进行比较,从而对药物疗效进行评价。
结果
1.理论研究结果在分析文献资料的基础上,阐述中医及西医对头面部术后肿胀的认识和治疗方法,提出中药马钱子去毒后可以制成安全有效的化瘀消肿药物,用于治疗面部整形术后肿胀。
2.实验研究结果
(1)成功制备出主药为马钱子优化总生物碱复合磷脂传递体的化瘀消肿凝胶。
(2)化瘀消肿凝胶抗炎消肿实验证明：抗炎实验中,末次给药后20min,剪耳称重,抗炎效果最佳。化瘀消肿凝胶能明显抑制小鼠的耳肿胀,与空白组比较有显著性差异,表明造模成功。化瘀消肿凝胶中马钱子优化总生物碱复合磷脂传递体的有效剂量为30mg·kg-1.其中中剂量组及高剂量组均能显著抵制小鼠的耳肿胀,但没有明显的量效关系。
3.临床研究结果
假体隆鼻术后使用化瘀消肿凝胶和冰敷均能促进术后肿胀的消退。化瘀消肿凝胶和冰敷相比促进鼻根部消肿效果更明显,具有统计学差异。
结论
本研究以马钱子为研究对象,基于组分中药思想,将马钱子优化总生物碱载入复合磷脂传递体,并制作成凝胶制剂,命名为化瘀消肿凝胶。将此凝胶用于消肿治疗,通过小鼠模型实验和临床试验证明此化瘀消肿凝胶在抗炎消肿治疗方面具有优越性,提高了经皮给药的生物利用度,促进药物高效率透皮吸收,为马钱子安全应用于术后外敷治疗术后肿胀提供了良好的样板,也是面部整形术后肿胀的一种有效的治疗手段。
Objective
This thesis aims to explore the therapeutic methods of reducing facial swelling after plastic surgery or speeding up the fading away of postoperative swelling. Semen strychni is an effective and riskless drug for clinical topical treatment of inflammatory swelling. And the transdermal absorption rate of composite phospholipid transfer body is high. Based on these advantages, we successfully invented a gel preparation named Hua Yu Xiao Zhong Ning Jiao which mainly compose of optimized Semen strychni total alkaloid compound phosphatide transfer body. To investigate the therapeutic effect of Hua Yu Xiao Zhong Ning Jiao on facial swelling after plastic surgery, We take an anti-inflammatory detumescence research on the mouse ear swelling model using the gel preparation. Furthermore, we observe the clinical treatment of the gel preparation on the rhinoplasty. The results provide reliable experimental data and theoretical basis for the clinical application of Hua Yu Xiao Zhong Ning Jiao on facial swelling after plastic surgery.
Methods
1. Theoretical methods:read traditional Chinese and Western medicine research literatures for analysis and comparison.
2. Experimental methods:
(1) Producation of the Hua Yu Xiao Zhong Ning Jiao. We make Hua Yu Xiao Zhong Ning Jiao by removing the toxic ingredients strychnine from semen strychni total alkaloid, extracting and purifying repercussive semen strychni optimized total alkaloid with no poison, loading it into composite phospholipid transfer body and conducting it into gel preparation.
(2) Anti-inflammatory detumescence research of the Hua Yu Xiao Zhong Ning Jiao. To make a mouse ear swelling model, we daub50μL xylene on the right ear and nothing on the left ear for comparison. PBS containing20%ethanol is givin to the blank control group. Meanwhile, Hua Yu Xiao Zhong Ning Jiao is givin to the treatment group. After the last drug treatment, we weigh and record the same round ear piece from all the ears. The ear swelling degree and inhibitory rate of swelling are calculated based on the weight. Similarly, we carry out experiments on the prevention effect of the gel preparation before molding, the last drug time interval and the identification of the best drug dose.
3. Clinical research methods:
This study applies random parallel comparison clinic trial method to observe120women who has been carried out rhinoplasty. The120cases are divided into6groups:bulk treatment group, silica gel treatment group, bulk control group, silica gel control group, bulk blank group and silica gel blank group,20cases of each group. Treatment group is provided with the Hua Yu Xiao Zhong Ning Jiao for15g once, which lasted for seven days. Control group is provided with ice for12hours per day, which lasted for seven days. Blank group is provided with nothing. The facial3D scanning, swelling thickness, swelling volume and swelling degree of all groups are recorded respectively at five different time points including the preoperative,1day postoperative,3days postoperative,5days postoperative and7days postoperative. We compared the overall treatment results and evaluated the drug curative effects of the Hua Yu Xiao Zhong Ning Jiao.
Results
1. Theoretical study results: Based on the analysis of the research literature, we elaborate the thoughts and therapeutic methods of Chinese medicine or Western medicine on facial swelling after plastic surgery. We figure out that the optimized traditional Chinese medicine semen strychni can be used as the main component of the Hua Yu Xiao Zhong Ning Jiao, and can be used in the treatment of facial swelling after plastic surgery.
2. The experimental results:
(1) Successful preparation of the Hua Yu Xiao Zhong Ning Jiao, which is mainly composed of optimized Semen strychni total alkaloid compound phosphatide transfer body.
(2) The anti-inflammatory detumescence experiments demonstrate that best anti-inflammatory time interval of Hua Yu Xiao Zhong Ning Jiao is20minutes after the treatment. The treatment can significantly inhibit mouse ear swelling compared with the blank control group, which demonstrate that the mouse model is successfully established. The effective dose of the Hua Yu Xiao Zhong Ning Jiao is30mg per kg(kilogram). Medium and high dose group could also resist the ear swelling of mice significantly, but there is no clear concentration-response relationship.
3. The results of clinical trials:
Both the Hua Yu Xiao Zhong Ning Jiao and the ice treatment can promote the fading of swelling on the whole nose after rhinoplasty. However, compared to ice treatment on nasal root swelling, the repercussive effect of Hua Yu Xiao Zhong Ning Jiao is more apparent, with statistical differences.
Conclusion
This study focus on a gel preparation named Hua Yu Xiao Zhong Ning Jiao which is made based on the component thoughts of of traditional Chinese medicine. It is made by extracting and purifying optimized semen strychni total alkaloid, being loaded into composite phospholipid transfer body and joined into a gel preparation. Through the mouse model experiments and clinical trials, we proved that the gel preparation has remarkable repercussive and anti-inflammatory effect on plastic surgery swelling. Also, it reveals that Hua Yu Xiao Zhong Ning Jiao enhances percutaneous drug bioavailability and promotes drug absorption through skin. Moreover, the study provides a good model for the application safety of semen strychni on extermal treatment after surgery swelling. It also provides an effective therapeutic method for the facial plastic surgery swelling.
探讨减轻面部整形术后肿胀或加快术后肿胀消退的治疗方法。根据马钱子碱外用治疗肿胀安全有效,将其复合磷脂传递体化后增加其透皮吸收率,成功制备出主药为马钱子优化总生物碱复合磷脂传递体的化瘀消肿凝胶。将此凝胶在小鼠耳致炎肿胀模型上进行抗炎消肿的实验研究,并进行隆鼻术后消肿治疗的临床观察,探讨化瘀消肿凝胶对面部整形术后肿胀的治疗效果,为化瘀消肿凝胶的临床应用提供可靠的实验数据和理论依据。
方法
1.理论研究阅读中西医学相关文献,整理分析。
2.实验研究
(1)制备化瘀消肿凝胶：从马钱子总生物碱中去除毒性成分士的宁,提取无毒的、有消肿作用的马钱子优化总生物碱,载入复合磷脂传递体,并制作成凝胶制剂,是为化瘀消肿凝胶。
(2)化瘀消肿凝胶抗炎消肿实验：将小鼠右耳涂抹二甲苯致肿,左耳不涂药作为对照造模。对照组给予含20%乙醇的PBS,给药组给予化瘀消肿凝胶,末次给药后用打孔器在左右两耳相同部位打下圆耳片,称重并记录,计算出耳肿胀度和抑肿率。同理,进行了预防给药后造模、末次给药间隔时间、最佳给药剂量等实验。
3.临床研究
采用随机平行对照的临床试验方法,观察进行假体(膨体或硅胶)隆鼻手术的女性患者病例数120例,共计分为六组：膨体治疗组、硅胶治疗组、膨体对照组、硅胶对照组、膨体空白组、硅胶空白组,每组20例。治疗组的患者从术后即刻予化瘀消肿凝胶外敷(15g/次)至术后第七天,对照组的患者从术后即刻予冰敷(12h/天)至术后第七天,空白组的患者手术区域不予任何处理。所有患者均于术前、术后1天、3天、5天、7天五个时间点分别进行面部三维扫描,通过软件分析得到不同时间点的肿胀厚度、肿胀体积及肿胀度进行比较,从而对药物疗效进行评价。
结果
1.理论研究结果在分析文献资料的基础上,阐述中医及西医对头面部术后肿胀的认识和治疗方法,提出中药马钱子去毒后可以制成安全有效的化瘀消肿药物,用于治疗面部整形术后肿胀。
2.实验研究结果
(1)成功制备出主药为马钱子优化总生物碱复合磷脂传递体的化瘀消肿凝胶。
(2)化瘀消肿凝胶抗炎消肿实验证明：抗炎实验中,末次给药后20min,剪耳称重,抗炎效果最佳。化瘀消肿凝胶能明显抑制小鼠的耳肿胀,与空白组比较有显著性差异,表明造模成功。化瘀消肿凝胶中马钱子优化总生物碱复合磷脂传递体的有效剂量为30mg·kg-1.其中中剂量组及高剂量组均能显著抵制小鼠的耳肿胀,但没有明显的量效关系。
3.临床研究结果
假体隆鼻术后使用化瘀消肿凝胶和冰敷均能促进术后肿胀的消退。化瘀消肿凝胶和冰敷相比促进鼻根部消肿效果更明显,具有统计学差异。
结论
本研究以马钱子为研究对象,基于组分中药思想,将马钱子优化总生物碱载入复合磷脂传递体,并制作成凝胶制剂,命名为化瘀消肿凝胶。将此凝胶用于消肿治疗,通过小鼠模型实验和临床试验证明此化瘀消肿凝胶在抗炎消肿治疗方面具有优越性,提高了经皮给药的生物利用度,促进药物高效率透皮吸收,为马钱子安全应用于术后外敷治疗术后肿胀提供了良好的样板,也是面部整形术后肿胀的一种有效的治疗手段。
Objective
This thesis aims to explore the therapeutic methods of reducing facial swelling after plastic surgery or speeding up the fading away of postoperative swelling. Semen strychni is an effective and riskless drug for clinical topical treatment of inflammatory swelling. And the transdermal absorption rate of composite phospholipid transfer body is high. Based on these advantages, we successfully invented a gel preparation named Hua Yu Xiao Zhong Ning Jiao which mainly compose of optimized Semen strychni total alkaloid compound phosphatide transfer body. To investigate the therapeutic effect of Hua Yu Xiao Zhong Ning Jiao on facial swelling after plastic surgery, We take an anti-inflammatory detumescence research on the mouse ear swelling model using the gel preparation. Furthermore, we observe the clinical treatment of the gel preparation on the rhinoplasty. The results provide reliable experimental data and theoretical basis for the clinical application of Hua Yu Xiao Zhong Ning Jiao on facial swelling after plastic surgery.
Methods
1. Theoretical methods:read traditional Chinese and Western medicine research literatures for analysis and comparison.
2. Experimental methods:
(1) Producation of the Hua Yu Xiao Zhong Ning Jiao. We make Hua Yu Xiao Zhong Ning Jiao by removing the toxic ingredients strychnine from semen strychni total alkaloid, extracting and purifying repercussive semen strychni optimized total alkaloid with no poison, loading it into composite phospholipid transfer body and conducting it into gel preparation.
(2) Anti-inflammatory detumescence research of the Hua Yu Xiao Zhong Ning Jiao. To make a mouse ear swelling model, we daub50μL xylene on the right ear and nothing on the left ear for comparison. PBS containing20%ethanol is givin to the blank control group. Meanwhile, Hua Yu Xiao Zhong Ning Jiao is givin to the treatment group. After the last drug treatment, we weigh and record the same round ear piece from all the ears. The ear swelling degree and inhibitory rate of swelling are calculated based on the weight. Similarly, we carry out experiments on the prevention effect of the gel preparation before molding, the last drug time interval and the identification of the best drug dose.
3. Clinical research methods:
This study applies random parallel comparison clinic trial method to observe120women who has been carried out rhinoplasty. The120cases are divided into6groups:bulk treatment group, silica gel treatment group, bulk control group, silica gel control group, bulk blank group and silica gel blank group,20cases of each group. Treatment group is provided with the Hua Yu Xiao Zhong Ning Jiao for15g once, which lasted for seven days. Control group is provided with ice for12hours per day, which lasted for seven days. Blank group is provided with nothing. The facial3D scanning, swelling thickness, swelling volume and swelling degree of all groups are recorded respectively at five different time points including the preoperative,1day postoperative,3days postoperative,5days postoperative and7days postoperative. We compared the overall treatment results and evaluated the drug curative effects of the Hua Yu Xiao Zhong Ning Jiao.
Results
1. Theoretical study results: Based on the analysis of the research literature, we elaborate the thoughts and therapeutic methods of Chinese medicine or Western medicine on facial swelling after plastic surgery. We figure out that the optimized traditional Chinese medicine semen strychni can be used as the main component of the Hua Yu Xiao Zhong Ning Jiao, and can be used in the treatment of facial swelling after plastic surgery.
2. The experimental results:
(1) Successful preparation of the Hua Yu Xiao Zhong Ning Jiao, which is mainly composed of optimized Semen strychni total alkaloid compound phosphatide transfer body.
(2) The anti-inflammatory detumescence experiments demonstrate that best anti-inflammatory time interval of Hua Yu Xiao Zhong Ning Jiao is20minutes after the treatment. The treatment can significantly inhibit mouse ear swelling compared with the blank control group, which demonstrate that the mouse model is successfully established. The effective dose of the Hua Yu Xiao Zhong Ning Jiao is30mg per kg(kilogram). Medium and high dose group could also resist the ear swelling of mice significantly, but there is no clear concentration-response relationship.
3. The results of clinical trials:
Both the Hua Yu Xiao Zhong Ning Jiao and the ice treatment can promote the fading of swelling on the whole nose after rhinoplasty. However, compared to ice treatment on nasal root swelling, the repercussive effect of Hua Yu Xiao Zhong Ning Jiao is more apparent, with statistical differences.
Conclusion
This study focus on a gel preparation named Hua Yu Xiao Zhong Ning Jiao which is made based on the component thoughts of of traditional Chinese medicine. It is made by extracting and purifying optimized semen strychni total alkaloid, being loaded into composite phospholipid transfer body and joined into a gel preparation. Through the mouse model experiments and clinical trials, we proved that the gel preparation has remarkable repercussive and anti-inflammatory effect on plastic surgery swelling. Also, it reveals that Hua Yu Xiao Zhong Ning Jiao enhances percutaneous drug bioavailability and promotes drug absorption through skin. Moreover, the study provides a good model for the application safety of semen strychni on extermal treatment after surgery swelling. It also provides an effective therapeutic method for the facial plastic surgery swelling.
引文
[1]徐道明,郭海英,张丽丽.创伤及术后肢体肿胀的康复治疗进展[J].中国康复.2011(2)：130-131.
[2]林章根.活血利水法治疗外伤性肿胀临床观察[J].实用中西医结合临床.2006(2)：46-47.
[3]管东辉.消肿袋外敷治疗外伤性肿胀的临床观察[J].中国中医骨伤科杂志.2010(12).
[4]位向东,盖小刚.消肿止痛膏外敷治疗四肢外伤性肿痛110例[J].中医外治杂志.2006(6)：31.
[5]张向荣,潘文军.生山栀外敷减轻创伤肿痛效果观察[J].中医正骨.2008(5).
[6]樊承红,夏世贞.芦荟在治疗睑袋整复术后肿胀中的运用[J].浙江中医杂志.2006(12)：720.
[7]张杰彪.外敷中药栀黄双柏散治软组织肿胀[J].浙江中医药大学学报.2008(2)：186-188.
[8]林彩霞,韩东伟,孙阿娟.“筋会”阳陵泉在软组织损伤中的临床应用[J].北京中医药大学学报.2009(5)：358-360.
[9]赵淑华,吉学群,许洪玲,等.血海穴活血化瘀功能的再评价[J].中国针灸.2004(7)：33-36.
[10]Patten J R, Patten J, Hutchins M O. Adjunct use of dexamethasone in postoperative dental pain control[J]. Compendium.1992,13(7):580,582,584.
[11]Neupert E , Lee J W, Philput C B, et al. Evaluation of dexamethasone for reduction of postsurgical sequelae of third molar removal[J]. J Oral Maxillofac Surg.1992,50(11):1177-1182,1182-1183.
[12]Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration:pathophysiologic effects and clinical implications[J]. J Am Coll Surg.2002,195(5):694-712.
[13]Brunon L, Lazo J, Parker K. Goodman Gilman's The Pharmacological Basis of Therapeutics, Brunton L, Lazo J, Parker K, New York:The McGraw Hill Companies,2005.
[14]Trindade P A, Giglio F P, Colombini-Ishikiriama B L, et al. Sublingual ketorolac and sublingual piroxicam are equally effective for postoperative pain, trismus, and swelling management in lower third molar removal[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2011.
[15]黄欣,麦慧,李建邦,等.强力脉痔灵治疗面部整形手术后水肿的临床观察[J].广西中医学院学报.2004(2)：33-34.
[16]侯秀英,钱会利,张宝林,等.马栗种子提取物增强重睑术后肿胀消退的疗效观察[J].中国药物与临床.2011(5)：566-567.
[17]Tolins S H. Treatment of varicose veins. An update[J]. Am J Surg.1983,145(2):248-252.
[18]王朝生,丁春,田诗政.消肿新药——强力脉痔灵[J].中国新药杂志.1998(5)：57-58.
[19]布仁,刘凯.舍雷肽酶肠溶片对重睑术后软组织肿胀的影响[J].中国新药与临床杂志.2008(9).
[20]Mazzone A, Catalani M, Costanzo M, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology:a multicentre, double-blind, randomized trial versus placebo[J]. J Int Med Res. 1990,18(5):379-388.
[21]陈柏芝.舍雷肽酶肠溶片对慢性鼻窦炎的疗效观察[J].今日药学.2009(9).
[22]潘珏,何礼贤.舍雷肽酶的药理作用及临床评价[J].中国新药与临床杂志.2008(8)：604-608.
[23]张文,冼国杰,强生庭,等.舍雷肽酶预防胸外科手术后肺不张[J].中国新药与临床杂志.2000(1)：72.
[24]殷凯生,付完珍,何礼贤,等.舍雷肽酶肠溶片黏痰溶解与祛痰疗效的多中心随机双盲对照临床研究[J].中国新药与临床杂志.2006(10)：737-740.
[25]Mecikoglu M, Saygi B, Yildirim Y, et al. The effect of proteolytic enzyme serratiopeptidase in the treatment of experimental implant-related infection[J]. J Bone Joint Surg Am.2006,88(6):1208-1214.
[26]张晓东,庾东春,刘学源.面部皮肤浅表损伤外用金因肽治疗的临床观察[J].中国美容医学.2009：22-23.
[27]杨艳芳,熊帮琴,杨小文,等.硬脂酸甘油脂局部涂搽减轻上颌窦术后反应研究[J].护理学杂志.2004(6).
[28]吴丽.局部放置云南白药预防下颌阻生智齿拔除术后并发症[J].农垦医学.2007(6).
[29]董辉,郭婷婷,周侠,等.口服云南白药对下颌阻生智齿拔除术后面部肿胀影响的评价[J].首都医科大学学报.2011(3)：421-425.
[30]江铭.消肿止痛汤治疗术后肿痛临床观察[J].中国现代药物应用.2010(11)：146.
[31]阴健,郭力弓.中药现代化研究与临床应用[M].学苑出版社,1993：132-136.
[32]樊承红,夏世贞.芦荟在治疗睑袋整复术后肿胀中的运用[J].浙江中医杂志.2006(12)：720.
[33]Deng X K, Yin W, Li W D, et al. The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism[J]. J Ethnopharmacol.2006,106(2):179-186.
[34]徐丽君,魏世超,陆付耳,等.马钱子若干组分治疗实验性关节炎的比较研究[J].同济医科大学学报.2001(6).
[35]Yin W, Wang T S, Yin F Z, et al. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica[J]. J Ethnopharmacol.2003,88(2-3):205-214.
[36]林明侠,张浩,徐涛.马钱子的毒理学研究[J].中医药信息.2002(1)：25-26.
[37]谭震宇.复方马钱子凝胶剂对大鼠痛阈值及血清IL-6表达水平的影响[J].中国中医急症.2011(8)：1267-1268.
[38]朱建伟,武继彪,李成韶,等.马钱子碱镇痛作用及其药效动力学研究[J].中国中医药科技.2005(3)：166-167.
[39]Chen J, Wang X, Qu Y G, et al. Analgesic and anti-inflammatory activity and pharmacokinetics of alkaloids from seeds of Strychnos nux-vomica after transdermal administration:effect of changes in alkaloid composition[J]. J Ethnopharmacol.2012,139(1):181-188.
[40]陈军,王立杰,蔡宝昌,等.马钱子碱经皮给药后在小鼠体内的药动学研究[J].中草药.2010(8)：1350-1352.
[41]李玲.电针配合马钱子外贴治疗三叉神经痛50例[J].中国民族民间医药杂志.2003(1)：33.
[42]孙玉明,李建春,宋金春.反相高效液相色谱法同时测定马钱子酊中士的宁和二甲氧基士的宁的含量[J].中国医院药学杂志.2002(9)：3233.
[43]周文英,杨准,李玉芝,等.HPLC法测定东乐膏中马钱子生物碱的含量[J].河北职工医学院学报.2000(4)：31-32.
[44]孙亦群,黄月纯,席萍.九分喷雾剂中士的宁和马钱子碱的含量测定[J].中国药业.2005(1)：36-37.
[45]姚慧芳.内服外贴治疗面瘫83例临床观察[J].吉林中医药.2002(6)：19.
[46]刘国芬,于淑卿.复方马钱子膏外敷治疗腱鞘炎[J].山东中医杂志.2002(11)：649.
[47]杨莉娅,谢松,吴云鸣,等.巴布剂复方紫荆消伤膏质量标准研究[J].中草药.2000(11)：28-30.
[48]郭立玮,王天山,潘扬,等.马钱子总碱涂膜剂透皮吸收研究[J].江苏药学与临床研究.1999(3)：6-8.
[49]郭立玮,王天山,殷飞,等.马钱子涂膜剂的研制[J].南京中医药大学学报.1997(2)：21-23.
[50]张路,简江波,袁媛,等.纳米马钱子碱脂质体制备工艺研究[J].中成药.2005(6)：632-637.
[51]李新圃,郁杰,罗金印,等.我国中草药透皮吸收研究现状[J].兽药与饲料添加剂.2002(4)：27-29.
[52]魏莉,蔡贞贞,徐莲英.阿魏酸透皮吸收的实验研究[J].中成药.1998(6)：1-2.
[53]李国锋,陈业豪,刘立捷,等.角质层与活性皮肤层对硝酸异山梨酯透皮吸收的影响[J].中国药师.2002(4)：199-201.
[54]刘强,吕志平,朱红霞.黄芩苷渗透不同动物皮肤的透皮吸收研究[J].中草药.2004(5)：37-39.
[55]唐宏生,郭善康.影响兽药透皮吸收因素的体外试验[J].广西农业科学.1998(3)：48-49.
[56]刘建平,李运曼,仇裕丰,等.氨茶碱膜剂的经皮吸收及穴位效应研究[J].中国药科大学学报.2000(5)：32-34.
[57]高玉升,杨吉田,韩剑文.透皮吸收促进剂对中药洋金花等药物释放的研究[J].中草药.1992,23(9)：465.
[58]王锐,郭俊华,张远.丹皮酚体外透皮吸收研究[J].中草药.1991,22(6)：226.
[59]戴伟礼,禹风英,李亦明.三种动物皮肤对外用药物的透皮吸收及其测定[J].中成药.1993(3)：7-8.
[60]孙考祥,徐凯建,张亚萍.中药透皮吸收研究概况[J].中国药学杂志.1996(1)：13-16.
[61]孙考祥,吴琳华,黄海燕,等.含不同透皮促进剂的丹参贴膏在体透皮吸收示踪研究[J].黑龙江医药.1998(1)：16-18.
[62]张庆祯,邵杰,毕秀英.伏天贴药疗法对1500例支气管哮喘的疗效观察[J].中国医药学报.：51-52.
[63]董征,华瑞成,杨润平,等.消喘膏对223例哮喘患者的10年疗效观察[J].中西医结合杂志.：336-337.
[64]王立军,韩桂芝,王集贤,等.青龙贴穴位敷贴法治疗支气管哮喘300例[J].中国中医药科技.1998(3)：177.
[65]张志平,蔡康荣,吴铁.薄荷脑促扑热息痛透过胎儿皮肤实验的电镜观察及其助渗机制的探讨[J].解剖学杂志.1994(1).
[66]许卫铭,王晖,冯小龙.皮肤性状改变后薄荷醇对甲硝唑透皮吸收作用的影响[J].中国临床药理学与治疗学.2002(1)：18-20.
[67]方晓阳,叶青.中药透皮吸收促进剂的研究与发展[J].中草药.2003(2)：96-100.
[68]朱铉,全香花,崔哲,等.杜香萜烯对安定透皮吸收作用影响的研究[J].延边大学医学学报.1998(1)：30-32.
[69]潘青叶,张仲源,徐莉.促进透皮吸收的中药(续完)[J].中医外治杂志.2001(4)：32-33.
[70]翁伟宇,徐惠南.川芎嗪体外透皮的特性[J].上海医科大学学报.：24-26.
[71]潘卫三,李华,李嘉煜.中药巴布剂研究的技术难点及解决方案[J].中医外治杂志.2004(3)：3-4.
[72]贾伟,高文远,王涛,等.中药巴布剂的研究现状[J].中国中药杂志.2003(1)：11-15.
[73]蔡宝昌,吴皓,杨秀伟,等.马钱子中16个生物碱类化合物13CNMR谱的数据分析[J].药学学报.1994(1)：44-48.
[74]贾旋旋,李文,李俊松,等.马钱子的毒性研究进展[J].中国中药杂志.2009(18)：2396-2399.
[75]于智敏,王克林,李海玉.常用有毒中药的毒性分析与配伍宜忌[M].北京：科学技术文献出版社,2005：59.
[76]胡巍,陈军,蔡宝昌,等.马钱子碱经皮给药的镇痛作用[J].中华中医药学刊.2008(2)：385-386.
[77]张水寒,杨永华,王实强,等.伤痛外搽宁中不同浓度乙醇对士的宁和马钱子碱透皮的影响[J].中药新药与临床药理.2000(6)：368-369.
[78]陈军,蔡宝昌,沈春云,等.马钱子总生物碱的含量测定[J].中药新药与临床药理.2007(6)：468-471.
[79]Knudsen N O, Jorgensen L, Hansen J, et al. Targeting of liposome-associated calcipotriol to the skin:effect of liposomal membrane fluidity and skin barrier integrity[J]. Int J Pharm.2011,416(2):478-485.
[80]杜芳,查选平,李世恒.一种非接触式三维形貌测量系统的设计与应用[J].计量技术.2005(4)：12-14.
[2]林章根.活血利水法治疗外伤性肿胀临床观察[J].实用中西医结合临床.2006(2)：46-47.
[3]管东辉.消肿袋外敷治疗外伤性肿胀的临床观察[J].中国中医骨伤科杂志.2010(12).
[4]位向东,盖小刚.消肿止痛膏外敷治疗四肢外伤性肿痛110例[J].中医外治杂志.2006(6)：31.
[5]张向荣,潘文军.生山栀外敷减轻创伤肿痛效果观察[J].中医正骨.2008(5).
[6]樊承红,夏世贞.芦荟在治疗睑袋整复术后肿胀中的运用[J].浙江中医杂志.2006(12)：720.
[7]张杰彪.外敷中药栀黄双柏散治软组织肿胀[J].浙江中医药大学学报.2008(2)：186-188.
[8]林彩霞,韩东伟,孙阿娟.“筋会”阳陵泉在软组织损伤中的临床应用[J].北京中医药大学学报.2009(5)：358-360.
[9]赵淑华,吉学群,许洪玲,等.血海穴活血化瘀功能的再评价[J].中国针灸.2004(7)：33-36.
[10]Patten J R, Patten J, Hutchins M O. Adjunct use of dexamethasone in postoperative dental pain control[J]. Compendium.1992,13(7):580,582,584.
[11]Neupert E , Lee J W, Philput C B, et al. Evaluation of dexamethasone for reduction of postsurgical sequelae of third molar removal[J]. J Oral Maxillofac Surg.1992,50(11):1177-1182,1182-1183.
[12]Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration:pathophysiologic effects and clinical implications[J]. J Am Coll Surg.2002,195(5):694-712.
[13]Brunon L, Lazo J, Parker K. Goodman Gilman's The Pharmacological Basis of Therapeutics, Brunton L, Lazo J, Parker K, New York:The McGraw Hill Companies,2005.
[14]Trindade P A, Giglio F P, Colombini-Ishikiriama B L, et al. Sublingual ketorolac and sublingual piroxicam are equally effective for postoperative pain, trismus, and swelling management in lower third molar removal[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2011.
[15]黄欣,麦慧,李建邦,等.强力脉痔灵治疗面部整形手术后水肿的临床观察[J].广西中医学院学报.2004(2)：33-34.
[16]侯秀英,钱会利,张宝林,等.马栗种子提取物增强重睑术后肿胀消退的疗效观察[J].中国药物与临床.2011(5)：566-567.
[17]Tolins S H. Treatment of varicose veins. An update[J]. Am J Surg.1983,145(2):248-252.
[18]王朝生,丁春,田诗政.消肿新药——强力脉痔灵[J].中国新药杂志.1998(5)：57-58.
[19]布仁,刘凯.舍雷肽酶肠溶片对重睑术后软组织肿胀的影响[J].中国新药与临床杂志.2008(9).
[20]Mazzone A, Catalani M, Costanzo M, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology:a multicentre, double-blind, randomized trial versus placebo[J]. J Int Med Res. 1990,18(5):379-388.
[21]陈柏芝.舍雷肽酶肠溶片对慢性鼻窦炎的疗效观察[J].今日药学.2009(9).
[22]潘珏,何礼贤.舍雷肽酶的药理作用及临床评价[J].中国新药与临床杂志.2008(8)：604-608.
[23]张文,冼国杰,强生庭,等.舍雷肽酶预防胸外科手术后肺不张[J].中国新药与临床杂志.2000(1)：72.
[24]殷凯生,付完珍,何礼贤,等.舍雷肽酶肠溶片黏痰溶解与祛痰疗效的多中心随机双盲对照临床研究[J].中国新药与临床杂志.2006(10)：737-740.
[25]Mecikoglu M, Saygi B, Yildirim Y, et al. The effect of proteolytic enzyme serratiopeptidase in the treatment of experimental implant-related infection[J]. J Bone Joint Surg Am.2006,88(6):1208-1214.
[26]张晓东,庾东春,刘学源.面部皮肤浅表损伤外用金因肽治疗的临床观察[J].中国美容医学.2009：22-23.
[27]杨艳芳,熊帮琴,杨小文,等.硬脂酸甘油脂局部涂搽减轻上颌窦术后反应研究[J].护理学杂志.2004(6).
[28]吴丽.局部放置云南白药预防下颌阻生智齿拔除术后并发症[J].农垦医学.2007(6).
[29]董辉,郭婷婷,周侠,等.口服云南白药对下颌阻生智齿拔除术后面部肿胀影响的评价[J].首都医科大学学报.2011(3)：421-425.
[30]江铭.消肿止痛汤治疗术后肿痛临床观察[J].中国现代药物应用.2010(11)：146.
[31]阴健,郭力弓.中药现代化研究与临床应用[M].学苑出版社,1993：132-136.
[32]樊承红,夏世贞.芦荟在治疗睑袋整复术后肿胀中的运用[J].浙江中医杂志.2006(12)：720.
[33]Deng X K, Yin W, Li W D, et al. The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism[J]. J Ethnopharmacol.2006,106(2):179-186.
[34]徐丽君,魏世超,陆付耳,等.马钱子若干组分治疗实验性关节炎的比较研究[J].同济医科大学学报.2001(6).
[35]Yin W, Wang T S, Yin F Z, et al. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica[J]. J Ethnopharmacol.2003,88(2-3):205-214.
[36]林明侠,张浩,徐涛.马钱子的毒理学研究[J].中医药信息.2002(1)：25-26.
[37]谭震宇.复方马钱子凝胶剂对大鼠痛阈值及血清IL-6表达水平的影响[J].中国中医急症.2011(8)：1267-1268.
[38]朱建伟,武继彪,李成韶,等.马钱子碱镇痛作用及其药效动力学研究[J].中国中医药科技.2005(3)：166-167.
[39]Chen J, Wang X, Qu Y G, et al. Analgesic and anti-inflammatory activity and pharmacokinetics of alkaloids from seeds of Strychnos nux-vomica after transdermal administration:effect of changes in alkaloid composition[J]. J Ethnopharmacol.2012,139(1):181-188.
[40]陈军,王立杰,蔡宝昌,等.马钱子碱经皮给药后在小鼠体内的药动学研究[J].中草药.2010(8)：1350-1352.
[41]李玲.电针配合马钱子外贴治疗三叉神经痛50例[J].中国民族民间医药杂志.2003(1)：33.
[42]孙玉明,李建春,宋金春.反相高效液相色谱法同时测定马钱子酊中士的宁和二甲氧基士的宁的含量[J].中国医院药学杂志.2002(9)：3233.
[43]周文英,杨准,李玉芝,等.HPLC法测定东乐膏中马钱子生物碱的含量[J].河北职工医学院学报.2000(4)：31-32.
[44]孙亦群,黄月纯,席萍.九分喷雾剂中士的宁和马钱子碱的含量测定[J].中国药业.2005(1)：36-37.
[45]姚慧芳.内服外贴治疗面瘫83例临床观察[J].吉林中医药.2002(6)：19.
[46]刘国芬,于淑卿.复方马钱子膏外敷治疗腱鞘炎[J].山东中医杂志.2002(11)：649.
[47]杨莉娅,谢松,吴云鸣,等.巴布剂复方紫荆消伤膏质量标准研究[J].中草药.2000(11)：28-30.
[48]郭立玮,王天山,潘扬,等.马钱子总碱涂膜剂透皮吸收研究[J].江苏药学与临床研究.1999(3)：6-8.
[49]郭立玮,王天山,殷飞,等.马钱子涂膜剂的研制[J].南京中医药大学学报.1997(2)：21-23.
[50]张路,简江波,袁媛,等.纳米马钱子碱脂质体制备工艺研究[J].中成药.2005(6)：632-637.
[51]李新圃,郁杰,罗金印,等.我国中草药透皮吸收研究现状[J].兽药与饲料添加剂.2002(4)：27-29.
[52]魏莉,蔡贞贞,徐莲英.阿魏酸透皮吸收的实验研究[J].中成药.1998(6)：1-2.
[53]李国锋,陈业豪,刘立捷,等.角质层与活性皮肤层对硝酸异山梨酯透皮吸收的影响[J].中国药师.2002(4)：199-201.
[54]刘强,吕志平,朱红霞.黄芩苷渗透不同动物皮肤的透皮吸收研究[J].中草药.2004(5)：37-39.
[55]唐宏生,郭善康.影响兽药透皮吸收因素的体外试验[J].广西农业科学.1998(3)：48-49.
[56]刘建平,李运曼,仇裕丰,等.氨茶碱膜剂的经皮吸收及穴位效应研究[J].中国药科大学学报.2000(5)：32-34.
[57]高玉升,杨吉田,韩剑文.透皮吸收促进剂对中药洋金花等药物释放的研究[J].中草药.1992,23(9)：465.
[58]王锐,郭俊华,张远.丹皮酚体外透皮吸收研究[J].中草药.1991,22(6)：226.
[59]戴伟礼,禹风英,李亦明.三种动物皮肤对外用药物的透皮吸收及其测定[J].中成药.1993(3)：7-8.
[60]孙考祥,徐凯建,张亚萍.中药透皮吸收研究概况[J].中国药学杂志.1996(1)：13-16.
[61]孙考祥,吴琳华,黄海燕,等.含不同透皮促进剂的丹参贴膏在体透皮吸收示踪研究[J].黑龙江医药.1998(1)：16-18.
[62]张庆祯,邵杰,毕秀英.伏天贴药疗法对1500例支气管哮喘的疗效观察[J].中国医药学报.：51-52.
[63]董征,华瑞成,杨润平,等.消喘膏对223例哮喘患者的10年疗效观察[J].中西医结合杂志.：336-337.
[64]王立军,韩桂芝,王集贤,等.青龙贴穴位敷贴法治疗支气管哮喘300例[J].中国中医药科技.1998(3)：177.
[65]张志平,蔡康荣,吴铁.薄荷脑促扑热息痛透过胎儿皮肤实验的电镜观察及其助渗机制的探讨[J].解剖学杂志.1994(1).
[66]许卫铭,王晖,冯小龙.皮肤性状改变后薄荷醇对甲硝唑透皮吸收作用的影响[J].中国临床药理学与治疗学.2002(1)：18-20.
[67]方晓阳,叶青.中药透皮吸收促进剂的研究与发展[J].中草药.2003(2)：96-100.
[68]朱铉,全香花,崔哲,等.杜香萜烯对安定透皮吸收作用影响的研究[J].延边大学医学学报.1998(1)：30-32.
[69]潘青叶,张仲源,徐莉.促进透皮吸收的中药(续完)[J].中医外治杂志.2001(4)：32-33.
[70]翁伟宇,徐惠南.川芎嗪体外透皮的特性[J].上海医科大学学报.：24-26.
[71]潘卫三,李华,李嘉煜.中药巴布剂研究的技术难点及解决方案[J].中医外治杂志.2004(3)：3-4.
[72]贾伟,高文远,王涛,等.中药巴布剂的研究现状[J].中国中药杂志.2003(1)：11-15.
[73]蔡宝昌,吴皓,杨秀伟,等.马钱子中16个生物碱类化合物13CNMR谱的数据分析[J].药学学报.1994(1)：44-48.
[74]贾旋旋,李文,李俊松,等.马钱子的毒性研究进展[J].中国中药杂志.2009(18)：2396-2399.
[75]于智敏,王克林,李海玉.常用有毒中药的毒性分析与配伍宜忌[M].北京：科学技术文献出版社,2005：59.
[76]胡巍,陈军,蔡宝昌,等.马钱子碱经皮给药的镇痛作用[J].中华中医药学刊.2008(2)：385-386.
[77]张水寒,杨永华,王实强,等.伤痛外搽宁中不同浓度乙醇对士的宁和马钱子碱透皮的影响[J].中药新药与临床药理.2000(6)：368-369.
[78]陈军,蔡宝昌,沈春云,等.马钱子总生物碱的含量测定[J].中药新药与临床药理.2007(6)：468-471.
[79]Knudsen N O, Jorgensen L, Hansen J, et al. Targeting of liposome-associated calcipotriol to the skin:effect of liposomal membrane fluidity and skin barrier integrity[J]. Int J Pharm.2011,416(2):478-485.
[80]杜芳,查选平,李世恒.一种非接触式三维形貌测量系统的设计与应用[J].计量技术.2005(4)：12-14.